T Ishida C, Kubota CS, Carlyle E, Tsukamoto T, Espenshade PJ., 2024, A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation, ACS Chem Biol., 19(8):1695-1704. doi: 10.1021/acschembio.4c00354. PMID: 39106256  PubMed